SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 5
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
|
presentations:
1 to
50 of
240
|
SYMPOSIUM: ADDING FUEL TO THE FIRE: SUBSTANCE USE AND HIV
CHASING THE DRAGON: OPIATES AND HIV
(ABSTRACT
63)
Ricky N Bluthenthal
University of Southern California, Los Angeles, CA, USA
SYMPOSIUM: ADDING FUEL TO THE FIRE: SUBSTANCE USE AND HIV
CHEMSEX AND IMPLICATIONS FOR HIV TRANSMISSION AND MANAGEMENT
(ABSTRACT
64)
Mark Rohan Pakianathan
St George's University Hospital, London, United Kingdom
SYMPOSIUM: ADDING FUEL TO THE FIRE: SUBSTANCE USE AND HIV
HIDDEN IN PLAIN SIGHT: THE ALCOHOL EPIDEMIC
(ABSTRACT
65)
Leickness Chisamu Simbayi
Human Sciences Research Council, Cape Town, South Africa
SYMPOSIUM: ADDING FUEL TO THE FIRE: SUBSTANCE USE AND HIV
TOBACCO SMOKING: THE SILENT KILLER
(ABSTRACT
66)
Lene Ryom
CHIP, Department of Infectious Diseases, Copenhagen, Denmark
SYMPOSIUM: ART AND REPRODUCTION
UPDATE ON ANTIRETROVIRAL DRUGS AND BIRTH DEFECTS
(ABSTRACT
59)
Lynne Meryl Mofenson
Elizabeth Glaser Pediatric AIDS Foundation, Silver Spring, MD, USA
SYMPOSIUM: ART AND REPRODUCTION
ART OPTIONS AND TREATMENT DECISIONS FOR WOMEN OF REPRODUCTIVE POTENTIAL
(ABSTRACT
60)
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
SYMPOSIUM: ART AND REPRODUCTION
POLICY AND PROGRAM DECISIONS FOR ART IN WOMEN OF REPRODUCTIVE POTENTIAL
(ABSTRACT
61)
Irene Mukui
Ministry of Health, Nairobi, Kenya
SYMPOSIUM: ART AND REPRODUCTION
CHALLENGES IN ANTIRETROVIRAL RESEARCH IN WOMEN OF REPRODUCTIVE POTENTIAL
(ABSTRACT
62)
Anne Drapkin Lyerly
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
SYMPOSIUM: HIV-ASSOCIATED TUMOR VIRUSES: PARTNERS IN CRIME
MODULATION OF HOST INNATE IMMUNITY BY KSHV
(ABSTRACT
55)
Blossom Damania
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
SYMPOSIUM: HIV-ASSOCIATED TUMOR VIRUSES: PARTNERS IN CRIME
EBV: IMMUNOPATHOGENESIS AND THE PATH TO AN EBV VACCINE
(ABSTRACT
56)
Jeffrey Cohen
NIAID, NIH, Bethesda, MD, USA
SYMPOSIUM: HIV-ASSOCIATED TUMOR VIRUSES: PARTNERS IN CRIME
HPV: NEW INSIGHTS INTO ONCOGENESIS AND OPPORTUNITIES FOR IMMUNE CONTROL
(ABSTRACT
57)
Denise Galloway
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
SYMPOSIUM: HIV-ASSOCIATED TUMOR VIRUSES: PARTNERS IN CRIME
HBV: FROM VIRAL INTEGRATION TO LIVER CANCER, IMPACT ON CURE STRATEGIES
(ABSTRACT
58)
Fabien Zoulim
INSERM, Lyon, France
SYMPOSIUM: COINFECTIONS: TUBERCULOSIS, HEPATITIS B AND C, AND HIV
DYNAMICS OF ACUTE HCV IN WESTERN EUROPE
(ABSTRACT
112)
Sanjay Bhagani
Royal Free Hospital, London, United Kingdom
SYMPOSIUM: COINFECTIONS: TUBERCULOSIS, HEPATITIS B AND C, AND HIV
A VACCINE TO PREVENT HCV: ARE WE GETTING THERE?
(ABSTRACT
113)
Andrea L Cox
Johns Hopkins University, Baltimore, MD, USA
SYMPOSIUM: COINFECTIONS: TUBERCULOSIS, HEPATITIS B AND C, AND HIV
CHOICES AND DILEMMAS: PREVENTING TUBERCULOSIS IN PEOPLE WITH HIV INFECTION
(ABSTRACT
114)
Amita Gupta
The Johns Hopkins University, Baltimore, MD, USA
SYMPOSIUM: COINFECTIONS: TUBERCULOSIS, HEPATITIS B AND C, AND HIV
TREATING MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REAL WORLD: NEW DRUGS AND REGIMENS
(ABSTRACT
115)
Jennifer Furin
Harvard Medical School, Boston, MA, USA
SYMPOSIUM: EXPRESS YOURSELF: PROVIRUS
THE CURRENT STATUS OF LATENCY REVERSING AGENTS
(ABSTRACT
108)
Carine M.C. Van Lint
Université Libre de Bruxelles, Gosselies, Belgium
SYMPOSIUM: EXPRESS YOURSELF: PROVIRUS
DISCOVERY AND CHARACTERIZATION OF A VIRUS-INTRINSIC HIV LATENCY CIRCUIT
(ABSTRACT
109)
Leor Weinberger
Gladstone Institutes | UCSF, San Francisco, CA, USA
SYMPOSIUM: EXPRESS YOURSELF: PROVIRUS
SILENCING OF RETROVIRAL GENE EXPRESSION BY THE HUSH COMPLEX
(ABSTRACT
110)
Stephen P Goff
Columbia University, New York, NY, USA
SYMPOSIUM: EXPRESS YOURSELF: PROVIRUS
THE POWER OF THE HIV PROMOTER: IMPACT OF HIV-DRIVEN VIRAL AND HOST GENE EXPRESSION
(ABSTRACT
111)
Ya-Chi Ho
Yale University School of Medicine, New Haven, CT, USA
SYMPOSIUM: THE STORY OF U: IMPLICATIONS OF UNDETECTABLE VIRAL LOAD ON TRANSMISSION
THE STORY OF U=U: SCIENTIFIC UNDERPINNINGS
(ABSTRACT
116)
Pietro L. Vernazza
Cantonal Hospital St. Gallen, St. Gallen, SG, Switzerland
SYMPOSIUM: THE STORY OF U: IMPLICATIONS OF UNDETECTABLE VIRAL LOAD ON TRANSMISSION
CARING FOR U: CLINICAL CONUNDRUMS
(ABSTRACT
117)
Nneka Nwokolo
Chelsea and Westminster Hospital, London, United Kingdom
SYMPOSIUM: THE STORY OF U: IMPLICATIONS OF UNDETECTABLE VIRAL LOAD ON TRANSMISSION
ME AND U: COMMUNITY PERSPECTIVES
(ABSTRACT
118)
Carrie Foote
IUPUI, Indianapolis, IN, USA
SYMPOSIUM: THE STORY OF U: IMPLICATIONS OF UNDETECTABLE VIRAL LOAD ON TRANSMISSION
MORE THAN U: MAXIMIZING POPULATION-LEVEL EFFECTS OF U=U
(ABSTRACT
119)
Andrew E Grulich
University of New South Wales, Sydney, NSW, Australia
SYMPOSIUM: GIRLS AND BOYS JUST WANT TO HAVE FUN: MAKING PREVENTION DESIRABLE FOR YOUTH
YOUNG TRANSGENDER INDIVIDUALS
(ABSTRACT
162)
Asa Radix
Callen-Lorde Community Health Center, New York, NY, USA
SYMPOSIUM: GIRLS AND BOYS JUST WANT TO HAVE FUN: MAKING PREVENTION DESIRABLE FOR YOUTH
ENGAGING YOUNG WOMEN IN SUB-SAHARAN AFRICA
(ABSTRACT
163)
Sinead Delany-Moretlwe
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
SYMPOSIUM: GIRLS AND BOYS JUST WANT TO HAVE FUN: MAKING PREVENTION DESIRABLE FOR YOUTH
MAKING PREVENTION WORK FOR YMSM: BRIDGING REAL-WORLD NEEDS THROUGH DIGITAL ENGAGEMENT
(ABSTRACT
164)
Lisa Hightow-Weidman
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
SYMPOSIUM: GIRLS AND BOYS JUST WANT TO HAVE FUN: MAKING PREVENTION DESIRABLE FOR YOUTH
DON'T LEAVE THEM BEHIND: HETEROSEXUAL YOUNG AFRICAN MEN
(ABSTRACT
165)
Webster Mavhu
Centre for Sexual Health & HIV/AIDS Research, Harare, Zimbabwe
SYMPOSIUM: GIRLS AND BOYS JUST WANT TO HAVE FUN: MAKING PREVENTION DESIRABLE FOR YOUTH
SYMPOSIUM: NEW CELLS ON THE BLOCK
TISSUE-RESIDENT MEMORY CD8+ CELLS
(ABSTRACT
154)
Michael R Betts
University of Pennsylvania, Philadelphia, PA, USA
SYMPOSIUM: NEW CELLS ON THE BLOCK
MECHANISMS UNDERLYING LOSS OF ILCS IN HIV/SIV-INFECTED INDIVIDUALS
(ABSTRACT
155)
Jason Brenchley
NIAID, NIH, Bethesda,MD, USA
SYMPOSIUM: NEW CELLS ON THE BLOCK
MEMORY NK CELLS AS NOVEL EFFECTORS AGAINST HIV AND SIV
(ABSTRACT
156)
R. Keith Reeves
Harvard Medical School/Beth Israel Deaconess Medical Center, Boston, MA, USA
SYMPOSIUM: NEW CELLS ON THE BLOCK
HIV SUPPRESSION BY CD8+ LYMPHOCYTES
(ABSTRACT
157)
Deanna Kulpa
Emory University, Atlanta, GA, USA
SYMPOSIUM: TOUGH QUESTIONS IN ANTIRETROVIRAL THERAPY MANAGEMENT
TRIBUTE TO DR ANREA DE LUCA
Andrea Antinori
Lazzaro Spallanzani National Institute for Infectious Diseases, Rome, Italy
Maurizio Zazzi
University of Siena, Siena, Italy
SYMPOSIUM: TOUGH QUESTIONS IN ANTIRETROVIRAL THERAPY MANAGEMENT
OBESITY: A GROWING PROBLEM IN ANTIRETROVIRAL THERAPY
(ABSTRACT
158)
John R. Koethe
Vanderbilt University Medical Center, Nashville, TN, USA
SYMPOSIUM: TOUGH QUESTIONS IN ANTIRETROVIRAL THERAPY MANAGEMENT
I KEEP FORGETTING: HIV, AGING, AND COGNITIVE DISORDERS
(ABSTRACT
159)
Victor Valcour
University of California, San Francisco, San Francisco, CA, USA
SYMPOSIUM: TOUGH QUESTIONS IN ANTIRETROVIRAL THERAPY MANAGEMENT
PREP FAILURES: DIAGNOSIS, RESISTANCE, AND TREATMENT
(ABSTRACT
160)
Jean-Michel Molina
Hôpital Saint-Louis, Paris, France
SYMPOSIUM: TOUGH QUESTIONS IN ANTIRETROVIRAL THERAPY MANAGEMENT
CAN TWO DRUGS TANGO: THE ROLE OF DUAL THERAPY
(ABSTRACT
161)
Laura Waters
Mortimer Market Center, London, United Kingdom
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
THE INFANT GUT: A GREAT DEFENSE SYSTEM?
(ABSTRACT
52)
Andrew Prendergast
Queen Mary University of London, London , United Kingdom
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
MOTHER-TO-CHILD TRANSMISSION OF HTLV-1
(ABSTRACT
53)
Antoine Gessain
Institut Pasteur, Paris, France
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
CAN WE ELIMINATE BREASTMILK TRANSMISSION OF HIV?
(ABSTRACT
54)
Ameena Goga
South African Medical Research Council, Cape Town, South Africa
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
ART IN BREASTMILK: DEFINING THE RISK-BENEFIT RATIO
(ABSTRACT
55)
Catriona Waitt
University of Liverpool, Liverpool, Merseyside, United Kingdom
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
THE GLOBAL BURDEN OF TUBERCULOSIS AND MODELING CONTROL STRATEGIES
(ABSTRACT
56)
Nimalan Arinaminpathy
Imperial College London, London, United Kingdom
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
USING WHOLE GENOME SEQUENCING TO BETTER UNDERSTAND TB TRANSMISSION DYNAMICS
(ABSTRACT
57)
Neel R Gandhi
Emory University, Atlanta, GA, USA
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
UNDIAGNOSED TUBERCULOSIS: PROMISE FOR PREVENTION
(ABSTRACT
58)
Neil A Martinson
Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg., Soweto, Gauteng, South Africa
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
NEW DEVELOPMENTS IN THE MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS
(ABSTRACT
59)
Serena Koenig
Brigham and Women's Hospital, Boston, MA, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
MECHANISMS OF EARLY CD8+ T CELL CONTROL
(ABSTRACT
48)
Jonah Sacha
Oregon Health & Science University, Portland, OR, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY BROADLY NEUTRALIZING ANTIBODY TREATMENT LEADING TO T-CELL CONTROL
(ABSTRACT
49)
Malcolm Martin
NIAID, NIH, Bethesda, MD, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
ANTI-ΑLPHA-4/ΒETA-7 ANTIBODY-MEDIATED CONTROL: UNDERSTANDING THE MECHANISM
(ABSTRACT
50)
James Arthos
NIH, Bethesda, MD, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY INTERVENTION THERAPIES IN HUMANS: ART, ANTIBODIES, AND VACCINES
(ABSTRACT
51)
Eugène Kroon
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
|
<< first | < prev
page:
of 5
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
|
presentations:
1 to
50 of
240
|
